Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade in Takayasu's Arteritis
NCT02457585Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of infliximab in Takayasu's arteritis (TAK), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
infliximab
03
Conditions
Takayasu's arteritis (TAK)
Beyond the preview
Go deeper on NCT02457585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457585.